MedDataX Logo

Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China（IVTIS）

NCT ID: NCT06131385

Last Updated: 2023-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-20

Study Completion Date

2046-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to observe the safety and effectiveness of intravenous thrombolysis for acute ischemic stroke in real-world clinical practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

IVTIS is a prospective, real-world registry lasting for 22 years. A total of 3000 patients with intravenous thrombolysis will be enrolled。

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acute ischemic stroke treated with intravenous thrombolysis

All of acute ischemic stroke patients who treated with intravenous thrombolysis.

intravenous thrombolysis

Intervention Type DRUG

Intravenous thrombolysis using thrombolytic drugs such as ateplase and teneplase.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intravenous thrombolysis

Intravenous thrombolysis using thrombolytic drugs such as ateplase and teneplase.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient was diagnosed with acute ischemic stroke and received intravenous thrombolysis.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zhengzhou Yuan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhengzhou Yuan

Deputy Director of Stroke Center

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zhengzhou Yuan

Role: STUDY_CHAIR

Department of Neurology, Affiliated Hospital of Southwest Medical University, Lu

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Affiliated Hospital of Southwest Medical University

Luzhou, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zhengzhou Yuan, MD

Role: CONTACT

[email protected]
+868303165661

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zhengzhou Yuan

Role: primary

+868303165661

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SWMU-2023-12

Identifier Type: -

Identifier Source: org_study_id